| pubmed-article:10621842 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10621842 | lifeskim:mentions | umls-concept:C1516213 | lld:lifeskim |
| pubmed-article:10621842 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:10621842 | lifeskim:mentions | umls-concept:C0278996 | lld:lifeskim |
| pubmed-article:10621842 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
| pubmed-article:10621842 | lifeskim:mentions | umls-concept:C0027530 | lld:lifeskim |
| pubmed-article:10621842 | lifeskim:mentions | umls-concept:C0030580 | lld:lifeskim |
| pubmed-article:10621842 | lifeskim:mentions | umls-concept:C0205092 | lld:lifeskim |
| pubmed-article:10621842 | lifeskim:mentions | umls-concept:C0023981 | lld:lifeskim |
| pubmed-article:10621842 | lifeskim:mentions | umls-concept:C2826285 | lld:lifeskim |
| pubmed-article:10621842 | lifeskim:mentions | umls-concept:C0442040 | lld:lifeskim |
| pubmed-article:10621842 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:10621842 | pubmed:dateCreated | 2000-1-20 | lld:pubmed |
| pubmed-article:10621842 | pubmed:abstractText | Radiotherapy (RT) is a common treatment for head and neck cancers, and frequently causes permanent salivary dysfunction and xerostomia. This 2-year longitudinal study evaluated unstimulated and stimulated parotid flow rates in 11 patients with head and neck cancers who received unilateral neck parotid-sparing RT. The results demonstrated that treated parotid glands had essentially no output up to 2 years post-RT. Alternatively, spared parotid flow rates were indistinguishable from pre-RT values at 1 and 2 years post-RT, and increased slightly over time. Total unstimulated and stimulated parotid flow rates 2 years after completion of RT were similar to pre-RT values, suggesting that spared parotid function may compensate for lost function from treated parotid glands. These results demonstrate that unilateral neck parotid-sparing techniques are effective in preserving contralateral parotid glands up to 2 years after the completion of RT. | lld:pubmed |
| pubmed-article:10621842 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10621842 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10621842 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10621842 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10621842 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10621842 | pubmed:month | May | lld:pubmed |
| pubmed-article:10621842 | pubmed:issn | 1368-8375 | lld:pubmed |
| pubmed-article:10621842 | pubmed:author | pubmed-author:D'HondtEE | lld:pubmed |
| pubmed-article:10621842 | pubmed:author | pubmed-author:ShipJ AJA | lld:pubmed |
| pubmed-article:10621842 | pubmed:author | pubmed-author:EisbruchAA | lld:pubmed |
| pubmed-article:10621842 | pubmed:author | pubmed-author:HensonB SBS | lld:pubmed |
| pubmed-article:10621842 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10621842 | pubmed:volume | 35 | lld:pubmed |
| pubmed-article:10621842 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10621842 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10621842 | pubmed:pagination | 234-41 | lld:pubmed |
| pubmed-article:10621842 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:10621842 | pubmed:meshHeading | pubmed-meshheading:10621842... | lld:pubmed |
| pubmed-article:10621842 | pubmed:meshHeading | pubmed-meshheading:10621842... | lld:pubmed |
| pubmed-article:10621842 | pubmed:meshHeading | pubmed-meshheading:10621842... | lld:pubmed |
| pubmed-article:10621842 | pubmed:meshHeading | pubmed-meshheading:10621842... | lld:pubmed |
| pubmed-article:10621842 | pubmed:meshHeading | pubmed-meshheading:10621842... | lld:pubmed |
| pubmed-article:10621842 | pubmed:meshHeading | pubmed-meshheading:10621842... | lld:pubmed |
| pubmed-article:10621842 | pubmed:meshHeading | pubmed-meshheading:10621842... | lld:pubmed |
| pubmed-article:10621842 | pubmed:meshHeading | pubmed-meshheading:10621842... | lld:pubmed |
| pubmed-article:10621842 | pubmed:meshHeading | pubmed-meshheading:10621842... | lld:pubmed |
| pubmed-article:10621842 | pubmed:meshHeading | pubmed-meshheading:10621842... | lld:pubmed |
| pubmed-article:10621842 | pubmed:meshHeading | pubmed-meshheading:10621842... | lld:pubmed |
| pubmed-article:10621842 | pubmed:meshHeading | pubmed-meshheading:10621842... | lld:pubmed |
| pubmed-article:10621842 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10621842 | pubmed:articleTitle | Two-year longitudinal study of parotid salivary flow rates in head and neck cancer patients receiving unilateral neck parotid-sparing radiotherapy treatment. | lld:pubmed |
| pubmed-article:10621842 | pubmed:affiliation | Department of Oral Medicine, Pathology, Oncology, University of Michigan School of Dentistry, USA. | lld:pubmed |
| pubmed-article:10621842 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10621842 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:10621842 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10621842 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10621842 | lld:pubmed |
